Haploinsufficiency for tumour suppressor genes: When you don't need to go all the way

Manuela Santarosa, Alan Ashworth

Research output: Contribution to journalArticle

Abstract

Classical tumour suppressor genes are thought to require mutation or loss of both alleles to facilitate tumour progression. However, it has become clear over the last few years that for some genes, haploinsufficiency, which is loss of only one allele, may contribute to carcinogenesis. These effects can either be directly attributable to the reduction in gene dosage or may act in concert with other oncogenic or haploinsufficient events. Here we describe the genes that undergo this phenomenon and discuss possible mechanisms that allow haploinsufficiency to display a phenotype and facilitate the pathogenesis of cancer.

Original languageEnglish
Pages (from-to)105-122
Number of pages18
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1654
Issue number2
DOIs
Publication statusPublished - Jun 7 2004

Fingerprint

Haploinsufficiency
Tumor Suppressor Genes
Alleles
Gene Dosage
Genes
Neoplasms
Carcinogenesis
Phenotype
Mutation

Keywords

  • Breast cancer
  • Calorectal cancer
  • Haploinsufficiency
  • Leukemia
  • Mutation
  • Prostate cancer
  • Tumour suppressor gene

ASJC Scopus subject areas

  • Biophysics
  • Cancer Research
  • Oncology

Cite this

Haploinsufficiency for tumour suppressor genes : When you don't need to go all the way. / Santarosa, Manuela; Ashworth, Alan.

In: Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1654, No. 2, 07.06.2004, p. 105-122.

Research output: Contribution to journalArticle

@article{963a71dbc11246f39169fef08e772e61,
title = "Haploinsufficiency for tumour suppressor genes: When you don't need to go all the way",
abstract = "Classical tumour suppressor genes are thought to require mutation or loss of both alleles to facilitate tumour progression. However, it has become clear over the last few years that for some genes, haploinsufficiency, which is loss of only one allele, may contribute to carcinogenesis. These effects can either be directly attributable to the reduction in gene dosage or may act in concert with other oncogenic or haploinsufficient events. Here we describe the genes that undergo this phenomenon and discuss possible mechanisms that allow haploinsufficiency to display a phenotype and facilitate the pathogenesis of cancer.",
keywords = "Breast cancer, Calorectal cancer, Haploinsufficiency, Leukemia, Mutation, Prostate cancer, Tumour suppressor gene",
author = "Manuela Santarosa and Alan Ashworth",
year = "2004",
month = "6",
day = "7",
doi = "10.1016/j.bbcan.2004.01.001",
language = "English",
volume = "1654",
pages = "105--122",
journal = "Biochimica et Biophysica Acta - Reviews on Cancer",
issn = "0304-419X",
publisher = "Elsevier B.V.",
number = "2",

}

TY - JOUR

T1 - Haploinsufficiency for tumour suppressor genes

T2 - When you don't need to go all the way

AU - Santarosa, Manuela

AU - Ashworth, Alan

PY - 2004/6/7

Y1 - 2004/6/7

N2 - Classical tumour suppressor genes are thought to require mutation or loss of both alleles to facilitate tumour progression. However, it has become clear over the last few years that for some genes, haploinsufficiency, which is loss of only one allele, may contribute to carcinogenesis. These effects can either be directly attributable to the reduction in gene dosage or may act in concert with other oncogenic or haploinsufficient events. Here we describe the genes that undergo this phenomenon and discuss possible mechanisms that allow haploinsufficiency to display a phenotype and facilitate the pathogenesis of cancer.

AB - Classical tumour suppressor genes are thought to require mutation or loss of both alleles to facilitate tumour progression. However, it has become clear over the last few years that for some genes, haploinsufficiency, which is loss of only one allele, may contribute to carcinogenesis. These effects can either be directly attributable to the reduction in gene dosage or may act in concert with other oncogenic or haploinsufficient events. Here we describe the genes that undergo this phenomenon and discuss possible mechanisms that allow haploinsufficiency to display a phenotype and facilitate the pathogenesis of cancer.

KW - Breast cancer

KW - Calorectal cancer

KW - Haploinsufficiency

KW - Leukemia

KW - Mutation

KW - Prostate cancer

KW - Tumour suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=2542432915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542432915&partnerID=8YFLogxK

U2 - 10.1016/j.bbcan.2004.01.001

DO - 10.1016/j.bbcan.2004.01.001

M3 - Article

C2 - 15172699

AN - SCOPUS:2542432915

VL - 1654

SP - 105

EP - 122

JO - Biochimica et Biophysica Acta - Reviews on Cancer

JF - Biochimica et Biophysica Acta - Reviews on Cancer

SN - 0304-419X

IS - 2

ER -